Psoriasis and the risk of incident diabetes mellitus: A population-based study

British Journal of Dermatology

Volumn 159, Issue 6, 2008, Pages 1331-1337

  Brauchli, Y B ^a   Jick, S S ^b   Meier, C R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Diabetes mellitus; Incidence; Psoriasis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; AZATHIOPRINE; BIGUANIDE DERIVATIVE; CALCIPOTRIOL; COAL TAR; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DITHRANOL DERIVATIVE; EMOLLIENT AGENT; ETRETIN; GUAR GUM; HYDROXYUREA; INSULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSORALEN; SALICYLIC ACID; SULFONYLUREA; TAZAROTENE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHILD; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; INCIDENCE; INCIDENTAL FINDING; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK FACTOR; ULTRAVIOLET A RADIATION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PSORIASIS; RISK; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 56549115792     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08814.x     Document Type: Article

References (35)

1. Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005 141 : 1537 41.
2. Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001 15 : 16 17.
3. Sabat R, Philipp S, Höflich C. Immunopathogenesis of psoriasis. Exp Dermatol 2007 16 : 779 98.
4. Fischer LM, Schlienger RG, Matter C et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004 93 : 198 200.
5. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005 125 : 61 7.
6. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986 172 : 298 304.
7. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 32 : 982 6.
8. Hotamisligil GS, Peraldi P, Budavari A et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996 271 : 665 8.
9. Bloomgarden ZT. Inflammation and insulin resistance. Diabetes Care 2003 26 : 1619 23.
10. Reynoso-von Drateln C, Martinez-Abundis E, Balcazar-Munoz BR et al. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. J Am Acad Dermatol 2003 48 : 882 5.
11. Boehncke S, Thaci D, Beschmann H et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007 157 : 1249 51.
12. Alexander E, Pinto J, Pal GS et al. Disease concomitance in psoriasis: a clinical study of 61 cases. Indian J Dermatol Venereol Leprol 2001 67 : 66 8.
13. Pearce DJ, Morrison AE, Higgins KB et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005 16 : 319 23.
14. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007 56 : 629 34.
15. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 298 : 321 8.
16. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 35.
17. Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007 157 : 68 73.
18. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997 350 : 1097 9.
19. Jick H. A database worth saving. Lancet 1997 350 : 1045 6.
20. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991 302 : 766 8.
21. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. Validity of the General Practice Research Database. Pharmacotherapy 2003 23 : 686 9.
22. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992 1 : 347 9.
23. Gelfand JM, Berlin J, van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003 139 : 1425 9.
24. Gelfand JM, Wang X, Qing L et al. Epidemiology and treatment patterns of psoriasis in the General Practice Research Database (GPRD). Pharmacoepidemiol Drug Saf 2005 14 (Suppl. S23.
25. Carlson C, Hornbuckle K, DeLisle F et al. Diabetes mellitus and antipsychotic treatment in the United Kingdom. Eur Neuropsychopharmacol 2006 16 : 366 75.
26. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH et al. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in the Netherlands (ZODIAC-1). Eur J Epidemiol 2003 18 : 793 800.
27. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol 2003 149 : 160 4.
28. Brauchli YB, Jick SS, Curtin F, Meier CR. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study. J Am Acad Dermatol 2008 58 : 421 9.
29. Buckingham BA, Sandborg CI. A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. Clin Immunol 2000 96 : 86 90.
30. Mrowietz U, Elder JT, Barker J. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res 2006 298 : 309 19.
31. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008 19 : 10 16.
32. Festa A, D'Agostino R Jr., Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000 102 : 42 7.
33. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005 48 : 1038 50.
34. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004 150 : 917 28.
35. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004 27 : 813 23.